| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Albiglutide Superior to Sitagliptin and Glimepiride in T2DM
|
Hitt, Emma
|
|
2013
|
13 |
17 |
p. 11-11
|
article
|
| 2 |
Bariatric Surgery in Type 2 Diabetes
|
Hoyle, Brian
|
|
2013
|
13 |
17 |
p. 34-35
|
article
|
| 3 |
Benefits of DPP-4 Inhibitors in Patients with Type 2 Diabetes and Cardiovascular Risk
|
Vinall, Maria
|
|
2013
|
13 |
17 |
p. 27-28
|
article
|
| 4 |
Cardiovascular Safety of Linagliptin Demonstrated in Pooled Analysis
|
Mosley, Mary
|
|
2013
|
13 |
17 |
p. 15-22
|
article
|
| 5 |
ENDURE: Alogliptin Effective and Safe through 2 Years
|
Mosley, Mary
|
|
2013
|
13 |
17 |
p. 22-22
|
article
|
| 6 |
Fixed-Ratio Combination of Insulin Degludec and Liraglutide Improves Glycemic Control in Type 2 Diabetes
|
Kuznar, Wayne
|
|
2013
|
13 |
17 |
p. 23-24
|
article
|
| 7 |
GLP-1 Based Therapies: Potential for Drug - Disease Interaction
|
Vinall, Maria
|
|
2013
|
13 |
17 |
p. 30-31
|
article
|
| 8 |
Glycemic Improvement with Canagliflozin is Durable in T2DM Patients on Metformin
|
Kuznar, Wayne
|
|
2013
|
13 |
17 |
p. 24-25
|
article
|
| 9 |
Improved Treatment of Type 2 Diabetes: Results from the 4B Trial
|
Hoyle, Brian
|
|
2013
|
13 |
17 |
p. 8-9
|
article
|
| 10 |
Initial Triple Therapy Superior to Stepwise Add-On Therapy in Newly Diagnosed Type 2 Diabetes
|
Kuznar, Wayne
|
|
2013
|
13 |
17 |
p. 26-26
|
article
|
| 11 |
LEADER Study: Testing the Cardiovascular Safety of Liraglutide
|
Mosley, Mary
|
|
2013
|
13 |
17 |
p. 14-15
|
article
|
| 12 |
Left Ventricular Remodeling Reduced with Olmesartan in ROADMAP
|
Mosley, Mary
|
|
2013
|
13 |
17 |
p. 13-14
|
article
|
| 13 |
Liraglutide is a Safe and Beneficial Adjunct to Insulin in Glycemic Control in Type 1 Diabetes
|
Hoyle, Brian
|
|
2013
|
13 |
17 |
p. 9-10
|
article
|
| 14 |
Long-Term Ranibizumab Effective in Diabetic Macular Edema
|
Nichols, Emma Hitt
|
|
2013
|
13 |
17 |
p. 13-13
|
article
|
| 15 |
Managing Dysglycemia in Diabetic Patients with Heart Failure
|
Vinall, Maria
|
|
2013
|
13 |
17 |
p. 36-37
|
article
|
| 16 |
New Basal Insulins: The Longer the Better?
|
Hoyle, Brian
|
|
2013
|
13 |
17 |
p. 37-37
|
article
|
| 17 |
New Insulin Glargine Formulation Associated with Less Nocturnal Hypoglycemia
|
Kuznar, Wayne
|
|
2013
|
13 |
17 |
p. 25-26
|
article
|
| 18 |
Once-Weekly Dulaglutide Produces Superior Glycemic Control Compared with Metformin
|
Hoyle, Brian
|
|
2013
|
13 |
17 |
p. 11-12
|
article
|
| 19 |
Once-Weekly Exenatide Allows Sustained HbA1C Control
|
Hoyle, Brian
|
|
2013
|
13 |
17 |
p. 9-9
|
article
|
| 20 |
Psychosocial Issues in Diabetes
|
Vinall, Maria
|
|
2013
|
13 |
17 |
p. 6-7
|
article
|
| 21 |
Review and Update of the United Kingdom Prospective Diabetes Study Trials
|
Vinall, Maria
|
|
2013
|
13 |
17 |
p. 4-5
|
article
|
| 22 |
Safety Still a Problem in Advanced Technology in Diabetes Care
|
Hitt, Emma
|
|
2013
|
13 |
17 |
p. 32-33
|
article
|
| 23 |
Should We Worry about Raised Triglycerides?
|
Hoyle, Brian
|
|
2013
|
13 |
17 |
p. 29-29
|
article
|
| 24 |
Trough DPP-4 Inhibition Differs between the Approved DPP-4 Inhibitors
|
Kuznar, Wayne
|
|
2013
|
13 |
17 |
p. 22-23
|
article
|
| 25 |
Type 1 Diabetes Impairs Education and Employment
|
Hitt, Emma
|
|
2013
|
13 |
17 |
p. 12-13
|
article
|
Journal description